Navigation Links
Testicular Cancer Patients Have Improved Reproductive Outcomes After Treatment

The survival rate of patients with testicular cancer has increased significantly over the past several years. What more, new research has now shown that fatherhood is a reachable possibility for many men who survive the disease.//

Testicular cancer is the most common form of cancer among men ages 20 to 40 and is slightly more common on the right side than on the left. The cause for the cancer is not known exactly. However, a combination of congenital (present right form birth) and acquired factors is believed to play a significant role.

The most common symptom associated with testicular cancer is painless enlargement of the testis accompanied by a sensation of heaviness. Self-examination plays a very important role in the early detection and treatment of testicular cancer. Surgery, radiotherapy and chemotherapy are the treatment options available.

A ray of hope left for the patients affected with testicular cancer is that it has a high cure rate, if detected early. However, the treatment has been known to affect the fertility potential of the patient. A follow up study combined with research purpose, conducted on a group of testicular cancer patients revealed that about one-third of the follow up patients attempted to father a child after treatment. Seventy-one percent of the men were successful within 15 years of treatment and 76 percent had the same success within 20 years.

Furthermore, the chance of successful conception was found to be dependent on the type of treatment as anticipated. Men treatment with high doses of chemotherapy had a 48 % success while the success rate for those followed by surveillance alone after the cancerous testicle was removed was much higher (92 %). Assisted reproductive techniques have helped these patients to a larger extent (22 %). The study results highlight the finding that the ability to conceive has increased over the years. It would be important however to preserve the sperm sample by c ryopreservation prior to chemotherapy as it is impossible to predict the fertility outcome on an individual basis.
'"/>




Related medicine news :

1. Fertility After Testicular Cancer Questioned
2. Life After Testicular Cancer
3. New Screening Method Found To Detect Testicular Cancer In Its Initial Stages
4. Testicular cancer linked to high cholesterol
5. Carboplatin Drug Is More Effective Than Radiation Therapy For Testicular Cancer
6. Treating Testicular Cancer With A Single Dose Of Chemotherapy
7. Testicular cancer identified
8. New Treatment Option For Testicular Cancer
9. Decline in Paternity Rates Following Treatment for Testicular Cancer
10. Human Testicular Cells Would Help In Stem Cell Research
11. An Eye on Increase in Testicular Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... ... April 28, 2016 , ... Trinity ... Tobacco-Free Kids, a leading force in the fight to reduce tobacco use and ... policies that can help reduce tobacco use. The initiative brings together two organizations ...
(Date:4/28/2016)... Illinois (PRWEB) , ... April ... ... the leading provider of enterprise Data Center Infrastructure Management solutions, announces today ... focuses on feature enhancements in the area of capacity management and optimization, ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... Aesthetic Surgery Education and Anzu®, developers of the AnzuMedical™ Knowledge Sharing and ... Surgery Collaborative Residency Network. The platform is scheduled to launch in July 2016 ...
(Date:4/28/2016)... ... April 28, 2016 , ... Accreditation Commission ... Oncology Pharmacy Association (COPA) to develop a comprehensive Specialty Pharmacy Accreditation with Distinction ... an accreditation distinction. ACHC provides a wide range of pharmacy accreditation services that ...
(Date:4/28/2016)... D.C. (PRWEB) , ... April 28, 2016 , ... The ... and Prevention (CDC) has established an ICD-10-CM code for sarcopenia, giving it recognition for ... the medical community effective October 1, 2016. , Sarcopenia is defined as a combination ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... , April 28, 2016 TapImmune,Inc. ... of innovative peptide and gene-based immunotherapeutics and vaccines for the ... be presenting at the 3rd Annual Growth Capital Expo ... th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... on Wednesday, May 4 th by Dr. John ...
(Date:4/27/2016)... --   , Total Sales ... Sales  Clinical sales grow 16% year-over-year  , ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser ... quarter ended March 31, 2016 and provided an update ... strategy. First Quarter 2016 Revenue Results by ...
Breaking Medicine Technology: